Skip to content

Endo- and extranasal sequelae of Treacher-Collins syndrome

Endo- and extranasal sequelae of Treacher-Collins syndrome - Nasal sequelae of Treacher-Collins syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37845
Enrollment
22
Registered
2012-07-11
Start date
2012-07-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treacher-Collins syndrome

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: diagnosis Treacher Collins syndrome informed consent ability to speak Dutch 18 years or above

Exclusion criteria

Exclusion criteria: no ability to speak Dutch age

Design outcomes

Primary

MeasureTime frame
Study parameters/endpoints Main study parameter/endpoint Main study parameters/endpoints will be a detailed description of all endo- and extranasal deformities (description of affected anatomical structures), nasal functioning and satisfaction with nasal appearance (as addressed in NAFEQ score).All are described in more detail in the -following- study procedures

Secondary

MeasureTime frame
Secondary endpoint is a change in the current treatment of TCS as will be described in (as part of ) a treatment protocol.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)